Clinical trial health tech firm eResearchTechnology (ERT) is getting a new CEO in the same week a report by The New York Times said its work on COVID-19 treatments was delayed due to a cyberattack.

PHILADELPHIA, July 7 -- ERT , a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, announced today the ...

Spruce Biosciences received FDA Breakthrough Therapy Designation for TA-ERT in treating San Filippo Syndrome Type B [MPS IIIB]. BTD enables potential rolling BLA submission, Priority Review, and ...

Leerink raised the firm’s price target on Spruce Biosciences (SPRB) to $160 from $10 and keeps a Market Perform rating on the shares. Spruce is ...

eResearchTechnology, Inc. (“ERT”), a leading global data and technology company which minimises risk and uncertainty in clinical trials, is pleased to announce an investment by Astorg, who will enter ...

As covid-19 has accelerated the use of technology in clinical trials, the pending merger of two such businesses backed by private equity – ERT and Bioclinica – assigns the combination a total ...

Ann Arbor, MI (September 21, 2010) – On-scene personnel accountability remains a critical problem for fire departments across the country. Basic hang-tag systems rely too heavily on manual steps to be ...

The Greek government has shut down the public broadcaster ERT, calling it a "haven of waste". Viewers watching the news on the main TV channel saw the screens go to black late on Tuesday evening. All ...